The Changing Diabetes® in Children programme was established to provide care and life-saving medicine for children with type 1 diabetes in low- and middle-income countries. The programme is committed to safegurading a healthy future for children with type 1 diabetes in countries where care is not always available or accessible.
The Changing Diabetes® in Children programme is a public-private partnership between the International Society for Pediatric and Adolescent Diabetes, the World Diabetes Foundation, Roche and Novo Nordisk. In each country where the programme has been established, local partners and national ministries of health have joined the global team to help deliver diabetes care to children with type 1 diabetes.
Type 1 diabetes has a high mortality rate among children living in low- and middle-income countries. In sub-Saharan Africa, the life expectancy for a child with newly diagnosed type 1 diabetes iis typically less than one year.
The Changing Diabetes® in Children programme takes a holistic approach to improving care, knowing that it takes more than medicine to create a better tomorrow.
Since 2009, the Changing Diabetes® in Children programme has expanded to 14 countries in Africa and Asia.
When a new partnership is established, the programme team begins working to address the country or community specific challenges, in aras such as the healthcare system, the medicine supply chain or the economic burden faced by families.
The programme is focused on six areas that address local challenges:
In the programme's first 10 years, more than 171 million DKK (26 million USD) has been invested in the programme. Through collaboration, knowledging sharing and strong partners, the Changing Diabetes® in Children programme aims to have 20,000 children enrolled in the programme by 2020.
If you're a healthcare professional or a parent/caregiver to a child diagnosed with type 1 diabetes, you are welcome to download, print, read and use our education materials to support the child through knowledge and dialogue.
We also offer a free to use training manual for healthcare
professionals around the topics:
Diagnosing diabetes in children, Treating diabetes, Talking to patients about diabetes and The organisation of diabetes care.
A set of 17 dialogue visuals developed for use in the clinic to
support the dialogue between the healthcare professional and the child
and the child's family or guardian.
The booklet covers questions like:
Why do I need insulin?, How much insulin should I take and where do I inject it?, How can I measure my blood glucose?, What are hypo- and hyperglycaemia and how to recognise them?
...and many other good questions when newly diagnosed with type 1 diabetes.
It is suggested that you use the materials together with the patient over a span of visits, concentrating on vital information at the first visit and repeating, as well as adding more information, at the subsequent visits.
Choose your preferred language and learn more in the guidelines.
The posters are designed to raise awareness of type 1 diabetes and reinforce some of the important messages about living with type 1 diabetes.
Choose from four different posters:
The training manual for healthcare professionals is to support education and training on important type 1 diabetes topics, including:
Novo Nordisk's Access to Insulin Commitment guarantees that the company will provide low-priced human insulin for people living with diabetes in low- and middle-income countries.
Today, the commitment covers 78 countries, home to 124 million people with diabetes, as well as selected humanitarian organisations operating in crisis areas.
In 2002, Novo Nordisk established the World Diabetes Foundation to invest hundreds of millions of dollars in the prevention and treatment of diabetes in low- and middle-income countries.
The Foundation’s network of public and private partners have helped shape the system of support for people with diabetes in countries around the world.